Rigel Pharmaceuticals stock price
라이절 파머슈티컬스NASDAQ:RIGL · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Rigel Pharmaceuticals last closed at $47.15 (+0.38%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is 2.9×. Its overall grade ranks 332 of 739 stocks in Healthcare.
About this company
Rigel Pharmaceuticals last closed at $47.15 (+0.38%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 332/739
Valuation grade D
Related stocks
- RocheCompetitor
면역·혈액질환 치료제에서 경쟁하는 글로벌 제약사
- NovartisCompetitor
혈액질환·면역질환 영역의 대형 경쟁 제약사
- AmgenCompetitor
혈액질환 및 염증성 질환 치료제 시장에서 경쟁
ETFs holding this stock
Virtus LifeSci Biotech Products ETF · First Trust Dow Jones Select MicroCap Index Fund · First Trust Active Factor Small Cap ETF
Details →About Rigel Pharmaceuticals
- What technical signals does Rigel Pharmaceuticals (RIGL) have?
- Rigel Pharmaceuticals current technical signals: no active technical signal.
- Is Rigel Pharmaceuticals a cup-and-handle pattern?
- No. Rigel Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Rigel Pharmaceuticals?
- Market cap: $855.84M. Trailing 12 months PER: 2.9×. Latest quarter PBR: 2.17×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Rigel Pharmaceuticals, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).